Brian Ledwith, PhD

Chairman of SAB

Brian has over 30 years of experience in nonclinical and clinical development across diverse modalities and therapeutic areas, in both large pharma and a mid-size biotech. He has also led global product development teams for programs at every stage of clinical development and post-licensure. Dr. Ledwith has an extensive publication record and history of successful interaction with regulatory bodies, and his work has been cited in regulatory guidelines for vaccines and gene therapy.

Meet more of the team